RESUMEN
Olfactory neuroblastoma is a rare tumor arising from the olfactory cleft region of the nasal cavity. Because of the low incidence of this tumor, as well as an absence of established cell lines and murine models, understanding the mechanisms driving olfactory neuroblastoma pathobiology has been challenging. Here, we sought to apply advances from research on the human olfactory epithelial neurogenic niche, along with new biocomputational approaches, to better understand the cellular and molecular factors in low- and high-grade olfactory neuroblastoma and how specific transcriptomic markers may predict prognosis. We analyzed a total of 19 olfactory neuroblastoma samples with available bulk RNA-sequencing and survival data, along with 10 samples from normal olfactory epithelium. A bulk RNA-sequencing deconvolution model identified a significant increase in globose basal cell (GBC) and CD8 T-cell identities in high-grade tumors (GBC from â¼0% to 8%, CD8 T cell from 0.7% to 2.2%), and significant decreases in mature neuronal, Bowman's gland, and olfactory ensheathing programs, in high-grade tumors (mature neuronal from 3.7% to â¼0%, Bowman's gland from 18.6% to 10.5%, olfactory ensheathing from 3.4% to 1.1%). Trajectory analysis identified potential regulatory pathways in proliferative olfactory neuroblastoma cells, including PRC2, which was validated by immunofluorescence staining. Survival analysis guided by gene expression in bulk RNA-sequencing data identified favorable prognostic markers such as SOX9, S100B, and PLP1 expression. Significance: Our analyses provide a basis for additional research on olfactory neuroblastoma management, as well as identification of potential new prognostic markers.
Asunto(s)
Estesioneuroblastoma Olfatorio , Neoplasias Nasales , Ratones , Humanos , Animales , Estesioneuroblastoma Olfatorio/genética , Mucosa Olfatoria/metabolismo , Vías Olfatorias/patología , Neoplasias Nasales/genética , ARN/metabolismoRESUMEN
OBJECTIVES: We investigated olfactory bulb (OB) volumes and olfactory sulcus (OS) depths in patients with rheumatoid arthritis (RA). METHODS: In this retrospective study, cranial magnetic resonance images of 68 adult patients were included. Group 1 consisted of 34 adult patients with RA. The control group (group 2) consisted of 34 adult patients without RA. In both groups, peripheral odor pathways (OB volumes and OS depths) were measured by magnetic resonance imaging. RESULTS: Our results showed that the OB volumes of the RA group were significantly lower than those in the control group bilaterally (P < 0.05). In each of the RA and control groups, the OS depth of the right side was found to be significantly higher than those on the left side (P < 0.05). On the left side, OS depth values of RA patients who used biological agents were significantly higher than those RA patients who did not use biological agents (P < 0.05). Correlation tests showed that there were positive correlations between OB volumes and OS depths bilaterally. In older patients with RA, bilateral OS depth values were decreased (P < 0.05). CONCLUSIONS: Our study has shown that the peripheral olfactory pathways in patients with RA can be affected to a degree that is reflected in anatomical measurements. The use of biological agents contributes to the protection of odor functions to a certain extent. The importance of evaluating the sense of smell in patients with RA clinically and radiologically should be emphasized.
Asunto(s)
Artritis Reumatoide , Bulbo Olfatorio , Vías Olfatorias , Corteza Prefrontal , Adulto , Artritis Reumatoide/diagnóstico por imagen , Artritis Reumatoide/epidemiología , Artritis Reumatoide/patología , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Bulbo Olfatorio/diagnóstico por imagen , Bulbo Olfatorio/patología , Vías Olfatorias/diagnóstico por imagen , Vías Olfatorias/patología , Corteza Prefrontal/diagnóstico por imagen , Corteza Prefrontal/patología , Estudios RetrospectivosRESUMEN
Prion diseases, or transmissible spongiform encephalopathies (TSEs), are a class of fatal neurodegenerative diseases caused by the entry and spread of infectious prion proteins (PrPSc) in the central nervous system (CNS). These diseases are endemic to certain mammalian animal species that use their sense of smell for a variety of purposes and therefore expose their nasal cavity (NC) to PrPSc in the environment. Prion diseases that affect humans are either inherited due to a mutation of the gene that encodes the prion protein, acquired by exposure to contaminated tissues or medical devices, or develop without a known cause (referred to as sporadic). The purpose of this review is to identify components of the NC that are involved in prion transport and to summarize the evidence that the NC serves as a route of entry (centripetal spread) and/or a source of shedding (centrifugal spread) of PrPSc, and thus plays a role in the pathogenesis of the TSEs.
Asunto(s)
Cavidad Nasal/patología , Mucosa Nasal/patología , Proteínas PrPSc/análisis , Enfermedades por Prión/patología , Animales , Humanos , Vías Olfatorias/patologíaRESUMEN
Olfactory neuropathology is a cause of olfactory loss in Alzheimer's disease (AD). Olfactory dysfunction is also associated with memory and cognitive dysfunction and is an incidental finding of AD dementia. Here we review neuropathological research on the olfactory system in AD, considering both structural and functional evidence. Experimental and clinical findings identify olfactory dysfunction as an early indicator of AD. In keeping with this, amyloid-ß production and neuroinflammation are related to underlying causes of impaired olfaction. Notably, physiological features of the spatial map in the olfactory system suggest the evidence of ongoing neurodegeneration. Our aim in this review is to examine olfactory pathology findings essential to identifying mechanisms of olfactory dysfunction in the development of AD in hopes of supporting investigations leading towards revealing potential diagnostic methods and causes of early pathogenesis in the olfactory system. [BMB Reports 2021; 54(6): 295-304].
Asunto(s)
Enfermedad de Alzheimer/complicaciones , Vías Nerviosas/patología , Enfermedades Neurodegenerativas/patología , Trastornos del Olfato/patología , Vías Olfatorias/patología , Animales , Humanos , Enfermedades Neurodegenerativas/etiología , Trastornos del Olfato/etiologíaRESUMEN
Spinal cord injury (SCI) is generally the consequence of physical damage, which may result in devastating consequences such as paraplegia or paralysis. Some certain candidates for SCI repair are olfactory ensheathing cells (OECs), which are unique glial cells located in the transition region of the peripheral nervous system and central nervous system and perform neuron regeneration in the olfactory system throughout life. Culture studies have clarified many properties of OECs, but their mechanisms of actions are not fully understood. Successful results achieved in animal models showcased that SCI treatment with OEC transplants is suitable for clinical trials. However, clinical trials are limited by difficulties like cell acquisition for autograft transplantation. Despite the improvements in both animal and clinical studies so far, there is still insufficient information about the mechanism of actions, adverse effects, proper application methods, effective subtypes, and sources of cells. This review summarizes pre-clinical and clinical literature focused on the cellular characterization of both OECs in vitro and post-transplantation. We highlight the roles and effects of OECs on (a) the injury-induced glial milieu, (b) neuronal growth/regeneration, and (c) functional recovery after injury. Due to the shown benefits of OECs with in vitro and animal studies and a limited number of clinical trials, where safety and effectivity were shown, it is necessary to conduct more studies on OECs to obtain effective and feasible treatment methods.
Asunto(s)
Neuroglía/efectos de los fármacos , Neuroglía/patología , Vías Olfatorias/efectos de los fármacos , Vías Olfatorias/patología , Traumatismos de la Médula Espinal/tratamiento farmacológico , Animales , Humanos , Bulbo Olfatorio/citología , Recuperación de la Función , Medicina RegenerativaRESUMEN
BACKGROUND: Post-viral olfactory dysfunction is a common cause of both short- and long-term smell alteration. The coronavirus pandemic further highlights the importance of post-viral olfactory dysfunction. Currently, a comprehensive review of the neural mechanism underpinning post-viral olfactory dysfunction is lacking. OBJECTIVES: To synthesize the existing primary literature related to olfactory dysfunction secondary to viral infection, detail the underlying pathophysiological mechanisms, highlight relevance for the current COVID-19 pandemic, and identify high impact areas of future research. METHODS: PubMed and Embase were searched to identify studies reporting primary scientific data on post-viral olfactory dysfunction. Results were supplemented by manual searches. Studies were categorized into animal and human studies for final analysis and summary. RESULTS: A total of 38 animal studies and 7 human studies met inclusion criteria and were analyzed. There was significant variability in study design, experimental model, and outcome measured. Viral effects on the olfactory system varies significantly based on viral substrain but generally include damage or alteration in components of the olfactory epithelium and/or the olfactory bulb. CONCLUSIONS: The mechanism of post-viral olfactory dysfunction is highly complex, virus-dependent, and involves a combination of insults at multiple levels of the olfactory pathway. This will have important implications for future diagnostic and therapeutic developments for patients infected with COVID-19.
Asunto(s)
COVID-19/complicaciones , Trastornos del Olfato/fisiopatología , Animales , COVID-19/epidemiología , COVID-19/patología , COVID-19/fisiopatología , Humanos , Trastornos del Olfato/epidemiología , Trastornos del Olfato/patología , Bulbo Olfatorio/patología , Mucosa Olfatoria/patología , Vías Olfatorias/patología , SARS-CoV-2/genética , SARS-CoV-2/patogenicidad , Especificidad de la Especie , Síndrome Post Agudo de COVID-19RESUMEN
Olfactory dysfunction is an early and prevalent symptom of Alzheimer's disease (AD) and the olfactory bulb is a nexus of beta-amyloid plaque and tau neurofibrillary tangle (NFT) pathology during early AD progression. To mitigate the accumulation of misfolded proteins, an endoplasmic reticulum stress response called the unfolded protein response (UPR) occurs in the AD hippocampus. However, chronic UPR activation can lead to apoptosis and the upregulation of beta-amyloid and tau production. Therefore, UPR activation in the olfactory system could be one of the first changes in AD. In this study, we investigated whether two proteins that signal UPR activation are expressed in the olfactory system of AD cases with low or high amounts of aggregate pathology. We used immunohistochemistry to label two markers of UPR activation (p-PERK and p-eIF2α) concomitantly with neuronal markers (NeuN and PGP9.5) and pathology markers (beta-amyloid and tau) in the olfactory bulb, piriform cortex, entorhinal cortex and the CA1 region of the hippocampus in AD and normal cases. We show that UPR activation, as indicated by p-PERK and p-eIF2α expression, is significantly increased throughout the olfactory system in AD cases with low (Braak stage III-IV) and high-level (Braak stage V-VI) pathology. We further show that UPR activation occurs in the mitral cells and in the anterior olfactory nucleus of the olfactory bulb where tau and amyloid pathology is abundant. However, UPR activation is not present in neurons when they contain NFTs and only rarely occurs in neurons containing diffuse tau aggregates. We conclude that UPR activation is prevalent in all regions of the olfactory system and support previous findings suggesting that UPR activation likely precedes NFT formation. Our data indicate that chronic UPR activation in the olfactory system might contribute to the olfactory dysfunction that occurs early in the pathogenesis of AD.
Asunto(s)
Enfermedad de Alzheimer/metabolismo , Neuronas/metabolismo , Vías Olfatorias/metabolismo , Respuesta de Proteína Desplegada/fisiología , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/patología , Péptidos beta-Amiloides/metabolismo , Factor 2 Eucariótico de Iniciación/análisis , Femenino , Humanos , Masculino , Persona de Mediana Edad , Ovillos Neurofibrilares/patología , Neuronas/patología , Vías Olfatorias/patología , eIF-2 Quinasa/análisis , Proteínas tau/metabolismoRESUMEN
The olfactory bulbs and tracts are central nervous system white matter tracts maintained by central neuroglia. Although rare, gliomas can originate from and progress to involve the olfactory apparatus. Through a Health Insurance Portability and Accountability Act-compliant retrospective review of the institutional teaching files and brain MR imaging reports spanning 10 years, we identified 12 cases of gliomas involving the olfactory bulbs and tracts, including 6 cases of glioblastoma, 2 cases of anaplastic oligodendroglioma, and 1 case each of pilocytic astrocytoma, diffuse (grade II) astrocytoma, anaplastic astrocytoma (grade III), and diffuse midline glioma. All except the pilocytic astrocytoma occurred in patients with known primary glial tumors elsewhere. Imaging findings of olfactory tumor involvement ranged from well-demarcated enhancing masses to ill-defined enhancing infiltrative lesions to nonenhancing masslike FLAIR signal abnormality within the olfactory tracts. Familiarity with the imaging findings of glioma involvement of the olfactory nerves is important for timely diagnosis and treatment of recurrent gliomas and to distinguish them from other disease processes.
Asunto(s)
Neoplasias Encefálicas/patología , Glioma/patología , Bulbo Olfatorio/patología , Vías Olfatorias/patología , Adolescente , Adulto , Anciano , Niño , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
CONTEXT: The reproductive axis is controlled by a network of gonadotropin-releasing hormone (GnRH) neurons born in the primitive nose that migrate to the hypothalamus alongside axons of the olfactory system. The observation that congenital anosmia (inability to smell) is often associated with GnRH deficiency in humans led to the prevailing view that GnRH neurons depend on olfactory structures to reach the brain, but this hypothesis has not been confirmed. OBJECTIVE: The objective of this work is to determine the potential for normal reproductive function in the setting of completely absent internal and external olfactory structures. METHODS: We conducted comprehensive phenotyping studies in 11 patients with congenital arhinia. These studies were augmented by review of medical records and study questionnaires in another 40 international patients. RESULTS: All male patients demonstrated clinical and/or biochemical signs of GnRH deficiency, and the 5 men studied in person had no luteinizing hormone (LH) pulses, suggesting absent GnRH activity. The 6 women studied in person also had apulsatile LH profiles, yet 3 had spontaneous breast development and 2 women (studied from afar) had normal breast development and menstrual cycles, suggesting a fully intact reproductive axis. Administration of pulsatile GnRH to 2 GnRH-deficient patients revealed normal pituitary responsiveness but gonadal failure in the male patient. CONCLUSIONS: Patients with arhinia teach us that the GnRH neuron, a key gatekeeper of the reproductive axis, is associated with but may not depend on olfactory structures for normal migration and function, and more broadly, illustrate the power of extreme human phenotypes in answering fundamental questions about human embryology.
Asunto(s)
Hormona Liberadora de Gonadotropina/metabolismo , Neuronas/fisiología , Nariz/anomalías , Trastornos del Olfato/congénito , Anomalías Múltiples/genética , Anomalías Múltiples/metabolismo , Anomalías Múltiples/patología , Anomalías Múltiples/fisiopatología , Adolescente , Adulto , Anciano , Niño , Preescolar , Estudios de Cohortes , Femenino , Hormona Folículo Estimulante/sangre , Hormona Liberadora de Gonadotropina/deficiencia , Gónadas/anomalías , Gónadas/patología , Humanos , Hipogonadismo/genética , Hipogonadismo/metabolismo , Hipogonadismo/patología , Hipogonadismo/fisiopatología , Lactante , Hormona Luteinizante/sangre , Masculino , Persona de Mediana Edad , Neurogénesis/fisiología , Neuronas/metabolismo , Trastornos del Olfato/genética , Trastornos del Olfato/metabolismo , Trastornos del Olfato/fisiopatología , Vías Olfatorias/metabolismo , Vías Olfatorias/patología , Tamaño de los Órganos , Adulto JovenRESUMEN
Studying olfaction with functional magnetic resonance imaging (fMRI) poses various methodological challenges. This study aimed to investigate the effects of stimulation length and repetition time (TR) on the activation pattern of 4 olfactory brain regions: the anterior and the posterior piriform cortex, the orbitofrontal cortex, and the insula. Twenty-two healthy participants with normal olfaction were examined with fMRI, with 2 stimulation lengths (6 s and 15 s) and 2 TRs (0.901 s and 1.34 s). Data were analyzed using General Linear Model (GLM), Tensorial Independent Component Analysis (TICA), and by plotting the event-related time course of brain activation in the 4 olfactory regions of interest. The statistical analysis of the time courses revealed that short TR was associated with more pronounced signal increase and short stimulation was associated with shorter time to peak signal. Additionally, both long stimulation and short TR were associated with oscillatory time courses, whereas both short stimulation and short TR resulted in more typical time courses. GLM analysis showed that the combination of short stimulation and short TR could result in visually larger activation within these olfactory areas. TICA validated that the tested paradigm was spatially and temporally associated with a functionally connected network that included all 4 olfactory regions. In conclusion, the combination of short stimulation and short TR is associated with higher signal increase and shorter time to peak, making it more amenable to standard GLM-type analyses than long stimulation and long TR, and it should, thus, be preferable for olfactory fMRI.
Asunto(s)
Imagen por Resonancia Magnética , Vías Olfatorias/fisiología , Olfato/fisiología , Adulto , Mapeo Encefálico , Humanos , Masculino , Odorantes , Vías Olfatorias/patología , Factores de TiempoRESUMEN
Evoked potentials are time-locked electrophysiologic potentials recorded in response to standardized stimuli using scalp electrodes. These responses provide good temporal resolution and have been used in various clinical and intraoperative settings. Olfactory evoked potentials (OEPs) may be used as an adjunct tool in identifying patients of Parkinson disease and Alzheimer dementia. In clinical practice, visual evoked potentials (VEPs) are particularly useful in identifying subclinical cases of optic neuritis and in treatment surveillance. In recent times, pattern electroretinograms and photopic negative response have been gaining attention in identifying glaucoma suspects. During surgical manipulation, there is a risk of damage to optic or olfactory nerve. Intraoperative neurophysiologic monitoring can provide information regarding the integrity of olfactory or visual pathway. OEPs and VEPs, however, show high degree of variability and are not reliable tools because the responses are extremely susceptible to volatile anesthetic agents. Newer techniques that could possibly circumvent these drawbacks have been developed but are not used extensively. In this article, we briefly review the available techniques to obtain OEPs and VEPs, diagnostic applications, the utility of intraoperative monitoring, the limitations of the current techniques, and the future directions for research.
Asunto(s)
Potenciales Evocados/fisiología , Monitoreo Intraoperatorio/métodos , Nervio Olfatorio/fisiopatología , Nervio Óptico/fisiopatología , Humanos , Vías Olfatorias/patología , Vías Olfatorias/fisiopatología , Pacientes Ambulatorios , Vías Visuales/patología , Vías Visuales/fisiopatologíaRESUMEN
BACKGROUND: Helicobacter pylori has changed radically gastroenterologic world, offering a new concept in patients' management. Over time, more medical data gave rise to diverse distant, extragastric manifestations and interactions of the "new" discovered bacterium. Special interest appeared within the field of neurodegenerative diseases and particularly Alzheimer's disease, as the latter and Helicobacter pylori infection are associated with a large public health burden and Alzheimer's disease ranks as the leading cause of disability. However, the relationship between Helicobacter pylori infection and Alzheimer's disease remains uncertain. METHODS: We performed a narrative review regarding a possible connection between Helicobacter pylori and Alzheimer's disease. All accessible relevant (pre)clinical studies written in English were included. Both affected pathologies were briefly analyzed, and relevant studies are discussed, trying to focus on the possible pathogenetic role of this bacterium in Alzheimer's disease. RESULTS: Data stemming from both epidemiologic studies and animal experiments seem to be rather encouraging, tending to confirm the hypothesis that Helicobacter pylori infection might influence the course of Alzheimer's disease pleiotropically. Possible main mechanisms may include the bacterium's access to the brain via the oral-nasal-olfactory pathway or by circulating monocytes (infected with Helicobacter pylori due to defective autophagy) through disrupted blood-brain barrier, thereby possibly triggering neurodegeneration. CONCLUSIONS: Current data suggest that Helicobacter pylori infection might influence the pathophysiology of Alzheimer's disease. However, further large-scale randomized controlled trials are mandatory to clarify a possible favorable effect of Helicobacter pylori eradication on Alzheimer's disease pathophysiology, before the recommendation of short-term and cost-effective therapeutic regimens against Helicobacter pylori-related Alzheimer's disease.
Asunto(s)
Enfermedad de Alzheimer/complicaciones , Enfermedad de Alzheimer/microbiología , Infecciones por Helicobacter/complicaciones , Helicobacter pylori/fisiología , Enfermedad de Alzheimer/fisiopatología , Animales , Barrera Hematoencefálica/patología , Tracto Gastrointestinal/microbiología , Infecciones por Helicobacter/epidemiología , Humanos , Vías Olfatorias/patologíaRESUMEN
BACKGROUND: Olfactory impairments are prominent in both schizophrenia and the preceding at-risk state. Their presence prior to illness predicts poor functional outcome. In schizophrenia, these impairments reflect peripheral olfactory structural abnormalities, which are hypothesized to arise during early embryonic development. If this is correct, then similar structural anomalies should be apparent among clinical high-risk subjects. METHODS: Thirty-nine clinical high-risk (CR) subjects (24M/15F) were compared to 36 low-risk (LR) subjects (19M/17F). Olfactory measures derived from 3T MRI scans included olfactory bulb volume, primary olfactory cortical gray matter volume, and the depth of the olfactory sulcus overlying the bulb. Additionally, nasal cavity volumes were assessed with acoustic rhinometry. RESULTS: Male CR subjects exhibited bilateral reductions in olfactory bulb volume and abnormal asymmetries of the posterior nasal cavities and olfactory sulci (left reduced relative to right). Post-hoc contrasts also indicated reduced left, but not right, olfactory cortical gray matter volume. Female CRs had no significant abnormalities, although they exhibited similar trend effects. Left olfactory bulb volume correlated, across all CR subjects, with negative, but not positive, symptoms. In a classification analysis, with 80% target specificity, olfactory measurements distinguished male CR from male LR subjects with 93% sensitivity. Among females, the comparable sensitivity was 69%. CONCLUSION: Psychosis-risk youths exhibit an array of sexually dimorphic and laterally asymmetric anomalies of the peripheral olfactory system. These are consistent with a developmental disruption primarily affecting male fetuses. These structural biomarkers may enhance the identification of at-risk subjects with poor prognosis, before their clinical trajectory is apparent.
Asunto(s)
Trastornos del Olfato/etiología , Trastornos del Olfato/patología , Vías Olfatorias/patología , Trastornos Psicóticos/complicaciones , Adolescente , Adulto , Femenino , Humanos , Masculino , Cavidad Nasal/diagnóstico por imagen , Cavidad Nasal/patología , Bulbo Olfatorio/diagnóstico por imagen , Bulbo Olfatorio/patología , Corteza Olfatoria/diagnóstico por imagen , Vías Olfatorias/diagnóstico por imagen , Psicofísica , Umbral Sensorial/fisiología , Factores Sexuales , Adulto JovenRESUMEN
Background: Evidence for olfactory dysfunction in schizophrenia has been firmly established. However, in the typical understanding of schizophrenia, olfaction is not recognized to contribute to or interact with the illness. Despite the solid presence of olfactory dysfunction in schizophrenia, its relation to the rest of the illness remains largely unclear. Here, we aimed to examine functional connectivity of the olfactory bulb, olfactory tract, and piriform cortices and isolate the network that would account for the altered olfaction in schizophrenia. Methods: We examined the functional connectivity of these specific olfactory regions in order to isolate other brain regions associated with olfactory processing in schizophrenia. Using the resting state functional MRI data from the Center for Biomedical Research Excellence in Brain Function and Mental Illness, we compared 84 patients of schizophrenia and 90 individuals without schizophrenia. Results: The schizophrenia group showed disconnectivity between the anterior piriform cortex and the nucleus accumbens, between the posterior piriform cortex and the middle frontal gyrus, and between the olfactory tract and the visual cortices. Conclusions: The current results suggest functional disconnectivity of olfactory regions in schizophrenia, which may account for olfactory dysfunction and disrupted integration with other sensory modalities in schizophrenia.
Asunto(s)
Mapeo Encefálico , Vías Olfatorias/patología , Esquizofrenia/complicaciones , Esquizofrenia/diagnóstico por imagen , Adulto , Estudios de Casos y Controles , Femenino , Lóbulo Frontal/diagnóstico por imagen , Lóbulo Frontal/patología , Humanos , Procesamiento de Imagen Asistido por Computador , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Trastornos del Olfato/diagnóstico por imagen , Trastornos del Olfato/etiología , Trastornos del Olfato/patología , Bulbo Olfatorio/diagnóstico por imagen , Bulbo Olfatorio/patología , Vías Olfatorias/diagnóstico por imagen , Oxígeno/sangre , Descanso , Esquizofrenia/patología , Adulto JovenRESUMEN
BACKGROUND: Olfactory impairment is an early manifestation of Parkinson's disease (PD). Diffusion Tensor Imaging (DTI) and Magnetization Transfer (MT) are two imaging techniques that allow noninvasive detection of microstructural changes in the cerebral white matter. OBJECTIVE: To assess white matter alterations associated with olfactory impairment in PD, using a binary imaging approach with DTI and MT. METHODS: 22 PD patients and 13 healthy controls were examined with DTI, MT and an odor discrimination test. DTI data were first analyzed with tract-based spatial statistics (TBSS) in order to detect differences in fractional anisotropy, mean, radial and axial diffusivity between PD patients and controls. Voxelwise randomized permutation was employed for the MT analysis, after spatial and intensity normalization. Additionally, ROI analysis was performed on both the DTI and MT data, focused on the white matter adjacent to olfactory brain regions. RESULTS: Whole brain voxelwise analysis revealed decreased axial diffusivity in the left uncinate fasciculus and the white matter adjacent to the left olfactory sulcus of PD patients. ROI analysis demonstrated decreased axial diffusivity in the right orbitofrontal cortex, as well as decreased mean diffusivity and axial diffusivity in the white matter of the left entorhinal cortex of PD patients. There were no significant differences regarding fractional anisotropy, radial diffusivity or MT between patients and controls. CONCLUSIONS: ROI analysis of DTI could detect microstructural changes in the white matter adjacent to olfactory areas in PD patients, whereas MT imaging could not.
Asunto(s)
Agnosia/diagnóstico por imagen , Encéfalo/patología , Imagen de Difusión Tensora , Imagen por Resonancia Magnética , Enfermedad de Parkinson/complicaciones , Enfermedad de Parkinson/diagnóstico por imagen , Sustancia Blanca/patología , Anciano , Agnosia/complicaciones , Encéfalo/diagnóstico por imagen , Discriminación en Psicología , Femenino , Humanos , Masculino , Vías Olfatorias/diagnóstico por imagen , Vías Olfatorias/patología , Enfermedad de Parkinson/psicología , Sustancia Blanca/diagnóstico por imagenRESUMEN
It was revealed that regeneration of the lateral olfactory tract (LOT) occurred in developing rats and the regenerated olfactory system was functional 4 weeks after transection. The aim of this study was to determine the earliest onset of functional recovery in LOT-injured rats and to quantify regenerated nerve components with functional correlation. Neonatal rats on postnatal day (P) 2 were subjected to unilateral transection of the left LOT and underwent unilateral removal of the right olfactory bulb on P11. Functional recovery of the tract injury was assessed by the suckling capability, which can be achieved by olfaction. Suckling capability was observed on P12 in most neonatally LOT-transected pups. Rat pups were subjected to unilateral transection of the left LOT on P2, and received injections of biotinylated dextran amine (BDA) into the bilateral olfactory bulb on P5 to quantify normal and regenerated nerve components in the olfactory cortices at the level of the olfactory tubercle. BDA(+) areas and density indices of the olfactory cortices in the neonatally LOT-transected P12 pups were 11.05×105µm2 and 0.35 on the normal right side and 4.34×105µm2 and 0.21 on the transected left side. We concluded that functional recovery of the LOT-transected neonatal rats occurred as early as 10days after tract transection and that areas and densities of regenerated nerve components essential for functional recovery were approximately 40% and 60% of the age-matched normal values in the olfactory cortices at the level of the olfactory tubercle.
Asunto(s)
Regeneración Nerviosa/fisiología , Bulbo Olfatorio/patología , Vías Olfatorias/lesiones , Vías Olfatorias/patología , Recuperación de la Función/fisiología , Olfato/fisiología , Animales , Animales Recién Nacidos , Biotina/análogos & derivados , Dextranos , Colorantes Fluorescentes , Trazadores del Tracto Neuronal , Bulbo Olfatorio/fisiopatología , Corteza Olfatoria/patología , Corteza Olfatoria/fisiopatología , Vías Olfatorias/fisiopatología , Ratas Wistar , Conducta en la Lactancia/fisiologíaRESUMEN
Los meningiomas del surco olfatorio representan el 10 por ciento de los meningiomas intracraneales, se originan de la lámina cribosa del etmoides, la sutura fronto-esfenoidal y el plano esfenoidal. Son tumores en su mayoría benignos y potencialmente curables, la recurrencia ocurre en grado variable siendo el grado de resección quirúrgica el predictor más importante de recurrencia. En este artículo se exponen los resultados alcanzados con el abordaje endonasal endoscópico extendido transcribiforme en pacientes con meningiomas del surco olfatorio en el servicio de neurocirugía del hospital clínico quirúrgico Hermanos Ameijeiras. La serie fue de 12 pacientes donde la cefalea, la anosmia y los trastornos neuropsicológicos fueron los síntomas predominantes. Los tumores tuvieron un tamaño ≥ a 6 cm en el 50 por ciento de los casos y con el abordaje endonasal endoscópico extendido transcribiforme se alcanzó una resección total con Simpson I en el 92 por ciento de los enfermos. Los límites del abordaje endonasal endoscópico en la fosa anterior se encuentran en constante extensión, siendo el abordaje endonasal endoscópico extendido transcribiforme la opción ideal y prometedora para los pacientes con Meningiomas del surco olfatorio.
Olfactory groove meningiomas represent 10 percent of intracranial meningiomas, originate from cribriform plate of ethmoid, frontal and sphenoid suture and the sphenoid plane. They are mostly benign and potentially curable tumors, the recurrence occurs in varying degree and the extent of surgical resection is the most important predictor of this recurrence. This article presents the results achieved with the transcribiform extended endoscopic endonasal approach in patients with meningiomas of olfactorygroove in neurosurgery department of the Hermanos Ameijeiras hospital. The series was of 12 patients where headache, anosmia, and neuropsychological disorders were the predominant symptoms. The tumors had a size ≥ 6 cm on 50 percent of the cases and with transcribiform extended endoscopic endonasal approach was reached total removal in 92 percent (Simpson I) of the patients. The limits of endoscopic endonasal approach for anterior fossa are in constant expansion, being the transcribiform extended endoscopic endonasal approach the ideal and promising option for patients with olfactory groove meningiomas.
Asunto(s)
Humanos , Masculino , Femenino , Persona de Mediana Edad , Cirugía Endoscópica por Orificios Naturales/métodos , Hueso Etmoides , Lóbulo Frontal , Fosa Craneal Anterior/patología , Meningioma/cirugía , Neoplasias de la Base del Cráneo/cirugía , Vías Olfatorias/patología , Diagnóstico por Imagen , Epidemiología Descriptiva , Meningioma/patología , Procedimientos Neuroquirúrgicos/métodos , Seno EsfenoidalRESUMEN
The olfactory deficits that occur during aging influence the quality of life and have been regarded as a risk factor for malnutrition in the elderly. The nucleus of the lateral olfactory tract (nLOT) is a cortical nucleus of the pallial amygdala that has been implicated in feeding behavior. Here we present quantitative data on the anatomy of the nLOT in the adult rat and on the effects of age on its structure and neurochemistry. Total neuron numbers, neuronal volumes, and volumes of layers 1-3 of the nLOT were estimated in adult and old male rats using stereological techniques. We also estimated the total number of interneurons expressing neuropeptide Y (NPY) and vasoactive intestinal polypeptide (VIP), and the numerical density of the nLOT cholinergic varicosities. Our data show that aging is associated with a reduction of the total neuron numbers in the nLOT, due to cell loss in layers 2 and 3. There were no age-related variations in neuronal volumes. Similarly, the volume of the nLOT was unchanged in aged rats, except in layer 3 where it was reduced. The numerical density of cholinergic varicosities was also unchanged in aged rats. Conversely, the total numbers of NPY- and VIP-immunoreactive neurons were reduced by 55% and 30%, respectively, in aged rats. These findings include the nLOT in the list of cortical olfactory structures susceptible to aging and raise the possibility that the age-related changes that occur in the nLOT might contribute for the decline in olfactory functions reported in normal aging.
Asunto(s)
Envejecimiento/patología , Neuronas/patología , Vías Olfatorias/patología , Envejecimiento/metabolismo , Animales , Recuento de Células , Tamaño de la Célula , Inmunohistoquímica , Masculino , Neuronas/metabolismo , Neuropéptido Y/metabolismo , Vías Olfatorias/metabolismo , Tamaño de los Órganos , Ratas Wistar , Péptido Intestinal Vasoactivo/metabolismoRESUMEN
Non motor symptoms (NMS) represent a significant burden in Parkinson's disease (PD) with numerous studies highlighting the importance of NMS both in "pre-motor" phase of PD as well as throughout the course of disease. In part this has led the international Parkinson and Movement Disorder Society (IPMDS) task force to attempt a re-definition of PD incorporating NMS and not base the diagnosis solely on motor symptoms. While motor subtypes within PD have been recognized and researched, recent clinical and neurobiological research suggests the existence of discrete non motor subtypes in PD, particularly in untreated (drug naïve) and early PD patients. Several independent observers have reported specific "clusters of NMS dominant PD" using a data driven approach in early and untreated PD patients while others have reported on the burden of NMS in untreated PD and specific NMS dominant phenotypes in untreated or treated PD using observational case series based data. In this review we report on specific NMS dominant phenotypes of PD as described in the literature using clinical observational studies and address pathophysiological concepts. A proposal for several NMS subtypes are reported combining clinical reports with, where possible, evidence base supporting probable biomarkers.
Asunto(s)
Enfermedad de Parkinson/clasificación , Enfermedad de Parkinson/diagnóstico , Fenotipo , Animales , Tronco Encefálico/patología , Trastornos del Conocimiento/clasificación , Trastornos del Conocimiento/diagnóstico , Trastornos del Conocimiento/epidemiología , Humanos , Trastornos de la Destreza Motora/clasificación , Trastornos de la Destreza Motora/diagnóstico , Trastornos de la Destreza Motora/epidemiología , Vías Olfatorias/patología , Enfermedad de Parkinson/epidemiología , Trastornos del Sueño-Vigilia/clasificación , Trastornos del Sueño-Vigilia/diagnóstico , Trastornos del Sueño-Vigilia/epidemiologíaRESUMEN
Multiple chemical sensitivity (MCS) patients usually react to odour compounds and the majority of neuroimaging studies assessed, especially at the cortical level, many olfactory-related correlates. The purpose of the present study was to depict sub-cortical metabolic changes during a neutral (NC) and pure (OC) olfactory stimulation by using a recently validated (18)F-2-fluoro-2-deoxy-D-glucose (FDG)-positron emission tomography/computer tomography procedure in 26 MCS and 11 healthy (HC) resting subjects undergoing a battery of clinical tests. Twelve subcortical volumes of interest were identified by the automated anatomical labeling library and normalized to thalamus FDG uptake. In both groups, when comparing OC to NC, the within-subjects ANOVA demonstrated a relative decreased metabolism in bilateral putamen and hippocampus and a relative increased metabolism in bilateral amygdala, olfactory cortex (OLF), caudate and pallidum. The between-groups ANOVA demonstrated in MCS a significant higher metabolism in bilateral OLF during NC. As in HC subjects negative correlations were found in OC between FDG uptake in bilateral amygdala and hippocampus and odor pleasantness scale, the latter positively correlated with MCS subjects' bilateral putamen FDG uptake in OC. Besides FDG uptake resemblances in both groups were found, for the first time a relative higher metabolism increase in OLF in MCS subjects at rest with respect to HC was found. When merging this aspect to the different subcortical FDG uptake correlations patterns in the two groups, the present study demonstrated to describe a peculiar metabolic index of behavioral and neurological aspects of MCS complaints.